Search for: All records

The spread of infectious diseases is a highly complex spatiotemporal process, difficult to understand, predict, and effectively respond to. Machine learning and artificial intelligence (AI) have achieved impressive results in other learning and prediction tasks; however, while many AI solutions are developed for disease prediction, only a few of them are adopted by decision-makers to support policy interventions. Among several issues preventing their uptake, AI methods are known to amplify the bias in the data they are trained on. This is especially problematic for infectious disease models that typically leverage large, open, and inherently biased spatiotemporal data. These biases may propagate through the modeling pipeline to decision-making, resulting in inequitable policy interventions. Therefore, there is a need to gain an understanding of how the AI disease modeling pipeline can mitigate biased input data, in-processing models, and biased outputs. Specifically, our vision is to develop a large-scale micro-simulation of individuals from which human mobility, population, and disease ground-truth data can be obtained. From this complete dataset—which may not reflect the real world—we can sample and inject different types of bias. By using the sampled data in which bias is known (as it is given as the simulation parameter), we can explore how existing solutions for fairness in AI can mitigate and correct these biases and investigate novel AI fairness solutions. Achieving this vision would result in improved trust in such models for informing fair and equitable policy interventions. 

COVID-19 pandemic has resulted in an over 60 % reduction in airtravel worldwide according to some estimates. The high economic and public perception costs of potential superspreading during air-travel necessitates research efforts that model, explain and mitigate disease spread. The long-duration exposure to infected passengers and the limited air circulation in the cabin are considered to be responsible for the infection spread during flight. Consequently, recent public health measures are primarily based on these aspects. However, a survey of recent on-flight outbreaks indicates that some aspects of the COVID-19 spread, such as long-distance superspreading, cannot be explained without also considering the movement of people. Another factor that could be influential but has not gained much attention yet is the unpredictable passenger behavior. Here, we use a novel infection risk model that is linked with pedestrian dynamics to accurately capture these aspects of infection spread. The model is parameterized through spatiotemporal analysis of a recent superspreading event in a restaurant in China. The passenger movement during boarding and deplaning, as well as the in-plane movement, are modeled with social force model and agent-based model respectively. We utilize the model to evaluate what-if scenarios on the relative effectiveness of policies and procedures such as masking, social distancing, as well as synergistic effects by combining different approaches in airplanes and other contexts. We find that in certain instances independent strategies can combine synergistically to reduce infection probability, by more than a sum of individual strategies 

We describe the complete capsid of a genotype C1-like Enterovirus A71 variant recovered from wastewater in a neighborhood in the greater Tempe, Arizona area (Southwest United States) in May 2020 using a pan-enterovirus amplicon-based high-throughput sequencing strategy. The variant seems to have been circulating for over two years, but its sequence has not been documented in that period. As the SARS-CoV-2 pandemic has resulted in changes in health-seeking behavior and overwhelmed pathogen diagnostics, our findings highlight the importance of wastewater-based epidemiology (WBE ) as an early warning system for virus surveillance. 

On January 26 2020, the first Coronavirus Disease 2019 (COVID-19) case was reported in Arizona of an individual with travel history (3^rdcase in the US) (1). Here, we report on early SARS-CoV-2 sentinel surveillance in Tempe, Arizona (USA). Genomic characterization identified an isolate encoding a 27 amino acid in-frame deletion in accessory protein ORF7a, the ortholog of SARS-CoV immune antagonist ORF7a/X4.